Colloidal gold, conjugated to ligands or antibodies, is routinely used
as a label for the detection of cell structures by light (LM) and electron
microscopy (EM). To date, several methods to count the number of colloidal
gold labels have been employed with limited success. Instrumental neutron
activation analysis (INAA), a physical method for the analysis of the
elemental composition of materials, can be used to provide a quantitative
index of gold accumulation in bulk specimens. Given that gold is not
naturally found in biological specimens in any substantial amount and that
colloidal gold and ligand conjugates can be prepared to yield uniform bead
sizes, the amount of label can be calculated in bulk biological samples by
INAA. Here we describe the use of INAA, LM, transmission EM, and X-ray
microanalysis (EDX) in a model to determine both distribution
(localization) and amount of colloidal gold at the organ, tissue,
cellular, and ultrastructural levels in whole animal systems following
administration. In addition, the sensitivity for gold in biological
specimens by INAA is compared with that of inductively coupled plasma-mass
spectrometry (ICP-MS). The correlative use of INAA, LM, TEM, and EDX can
be useful, for example, in the quantitative and qualitative tracking of
various labeled molecular species following administration in vivo.